Alpha Teknova, Inc.

Healthcare

NASDAQ:TKNO · NASDAQ Global Market

Market Cap $225.18M Beta 0.63 P/E (TTM) -13.1

$4.20 -4.55%

-$0.20 today

52W Low $1.91High $6.68

Vol 0.15M · Avg 0.13M

EPS (TTM)-$0.32

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-23.36%

Period High

$6.37

Period Low

$1.99

Latest

$4.20

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

BioAge Labs, Inc.

NASDAQ:BIOA

$679.20M

Ironwood Pharmaceuticals, Inc.

NASDAQ:IRWD

$600.84M

Canopy Growth Corporation

NASDAQ:CGC

$425.84M

NeoGenomics, Inc.

NASDAQ:NEO

$290.37M

Lifecore Biomedical, Inc.

NASDAQ:LFCR

$211.55M

Aurora Cannabis Inc.

NASDAQ:ACB

$172.40M

ProQR Therapeutics N.V.

NASDAQ:PRQR

$151.72M

CVRx, Inc.

NASDAQ:CVRX

$133.48M

Exagen Inc.

NASDAQ:XGN

$112.83M

Immutep Limited

NASDAQ:IMMP

$53.60M

What is the latest TKNO filing?

The latest filing shown is 4 dated Jun 2, 2026.

How many recent filings does TKNO have?

Intrinsic Alpha currently shows 20 recent filings for TKNO.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.